Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

ASX:MAQ
ASX:MAQIT

Why Macquarie Technology Group (ASX:MAQ) Is Down 7.2% After Reporting Higher Sales But Lower Earnings

Macquarie Technology Group Limited recently reported its half-year results to December 31, 2025, with sales rising to A$193.38 million from A$183.62 million a year earlier, while net income eased to A$16.33 million and basic earnings per share from continuing operations slipped to A$0.634. The combination of higher revenue but lower profit and earnings per share highlights pressure on margins and cost management during the period. We’ll now examine how this mix of higher sales but lower...
ASX:AUB
ASX:AUBInsurance

A Look At AUB Group’s Valuation As New Equity Raise And Insider Buying Support Growth Plans

AUB Group (ASX:AUB) has just completed a follow on equity offering of A$10.57m at A$23.62 per share, adding 447,640 new ordinary shares and coinciding with fresh share purchases from the CEO and directors. See our latest analysis for AUB Group. The recent equity raise comes after a softer run for the shares, with a 30 day share price return of a 13.52% decline and a 90 day share price return of a 23.18% decline. The 5 year total shareholder return of 57.98% contrasts with weaker 1 and 3 year...
TSX:NPI
TSX:NPIRenewable Energy

Assessing Northland Power (TSX:NPI) Valuation After Strong Q4 Revenue And Net Income Growth

Northland Power (TSX:NPI) is back in focus after reporting fourth quarter 2025 results, with sales of CA$722.84 million, revenue of CA$725.26 million, and net income of CA$289.82 million. See our latest analysis for Northland Power. At a share price of CA$21.25, Northland Power has delivered a 24.12% 90 day share price return and a 14.38% 1 year total shareholder return, hinting at improving momentum after weaker multi year total returns. If this earnings update has you looking beyond a...
NYSE:AMH
NYSE:AMHResidential REITs

The Bull Case For American Homes 4 Rent (AMH) Could Change Following Share Buyback And Softer Rental Demand

In late February and early March 2026, analysts including Citi, Raymond James, and Barclays turned more cautious on American Homes 4 Rent, citing softer rental demand, elevated new supply, and rising concessions across single-family and multifamily markets. At Citi’s Miami Global Property CEO Conference 2026, American Homes 4 Rent outlined its response with a new US$500 million share repurchase authorization and plans to develop about 1,900 homes in 2026 while closely tracking legislative...
ASX:SMR
ASX:SMRMetals and Mining

Stanmore Resources (ASX:SMR) Lifts Dividend Despite 2025 Loss Is Its Capital Strategy Shifting?

Stanmore Resources Limited recently reported full-year 2025 results showing revenue of US$1.89 billion, down from US$2.50 billion in 2024, and a net loss of US$47.2 million compared with prior-year net income of US$191.5 million. Despite swinging to a loss, the company lifted its fully franked ordinary dividend to US$0.089 per share, signalling confidence in cash generation supported by record saleable coal production of 14.0 Mt amid earlier weather disruptions. We’ll now examine how...
NasdaqGS:SWBI
NasdaqGS:SWBILeisure

A Look At Smith & Wesson (SWBI) Valuation After Quarterly Earnings And Dividend Announcement

Quarterly earnings and dividend catch investors’ attention Smith & Wesson Brands (SWBI) recently reported third quarter results alongside a fresh dividend announcement. This gives investors new data on both operating performance and direct cash returns. For the quarter ended January 31, 2026, sales were US$135.71 million compared with US$115.89 million a year earlier, while net income was US$3.75 million versus US$2.10 million. See our latest analysis for Smith & Wesson Brands. The earnings...
NasdaqGM:NRIX
NasdaqGM:NRIXBiotechs

Does Nurix Therapeutics' (NRIX) Expanded ATM Capacity Reframe Its Balance Between Funding Flexibility and Dilution?

Nurix Therapeutics recently amended its equity distribution agreement to allow sales of up to US$413.65 million of common stock through Piper Sandler under its existing shelf registration. This expanded at-the-market facility gives Nurix added funding flexibility, potentially affecting how investors assess its balance between capital needs and ownership dilution. We will now examine how this enlarged at-the-market capacity shapes Nurix’s investment narrative, particularly around funding...
BME:TRE
BME:TREEnergy Services

A Look At Técnicas Reunidas (BME:TRE) Valuation After 2026 Guidance And Strong 2025 Results

Técnicas Reunidas (BME:TRE) drew investor attention after issuing 2026 guidance, targeting sales above €6.5b, EBIT above €325m and net profit around €200m, shortly after releasing stronger full year 2025 results. See our latest analysis for Técnicas Reunidas. The latest guidance and 2025 results landed after a sharp 14.99% 7 day share price pullback. Even so, Técnicas Reunidas still sits at €31.42 with a 10.17% 90 day share price return and a very large 1 year total shareholder return of...
NasdaqGS:DSGR
NasdaqGS:DSGRTrade Distributors

Assessing Distribution Solutions Group (DSGR) Valuation After Earnings Miss And Rising Legal Scrutiny

What triggered the latest move in Distribution Solutions Group? Distribution Solutions Group (DSGR) is back in focus after its fourth quarter and full year 2025 earnings missed analyst expectations on both revenue and earnings, pressuring margins and sparking legal scrutiny following a sharp share price reaction. See our latest analysis for Distribution Solutions Group. The sharp post earnings drop has fed into a wider reset in expectations, with a 7 day share price return of 26.12% and a...
OB:HAUTO
OB:HAUTOShipping

Assessing Höegh Autoliners (OB:HAUTO) Valuation After Mixed Revenue Growth And Profitability Pressures

Höegh Autoliners (OB:HAUTO) has drawn fresh attention after reporting mixed fourth quarter and full year 2025 results, with higher sales set against weaker profitability, and confirming a cash dividend alongside an upcoming investor conference appearance. See our latest analysis for Höegh Autoliners. Against this mixed earnings backdrop, Höegh Autoliners’ share price at NOK132.5 reflects a strong 30 day share price return of 22.35% and 90 day return of 37.81%. The 1 year total shareholder...
ASX:TNE
ASX:TNESoftware

The Bull Case For Technology One (ASX:TNE) Could Change Following ASX 50 Exit And Hyperion Trim

Technology One, a major Australian enterprise software provider, was recently removed from the S&P/ASX 50 index after S&P Dow Jones Indices’ March 2026 quarterly rebalance, while Hyperion Asset Management reduced its position below the substantial holding threshold. Together, the index exclusion and shift in institutional ownership could alter Technology One’s visibility among passive funds and reshape perceptions of its shareholder base. We’ll now explore how Technology One’s removal from...
NasdaqCM:MOBX
NasdaqCM:MOBXSemiconductor

Mobix Labs (MOBX) Is Up 530.3% After New Defense-Aerospace Orders and Quorum Shift - Has The Bull Case Changed?

In early March 2026, Mobix Labs, Inc. reported new production purchase orders for its high-reliability electromagnetic interference protection components used in Gulfstream business jets and the U.S. Navy’s Tomahawk cruise missile program, alongside a change to its bylaws reducing the shareholder meeting quorum requirement to one-third of voting power. The fresh aerospace and defense orders underline Mobix Labs’ role as an already-qualified supplier embedded in mission-critical platforms...
ASX:VEA
ASX:VEAOil and Gas

Viva Energy Group (ASX:VEA) Valuation Check After Wider Loss And Fully Franked Dividend Decision

Dividend and earnings update Viva Energy Group (ASX:VEA) has put two big pieces of news on the table at once, a fully franked dividend declaration alongside full year 2025 results showing a wider net loss. The company declared an ordinary fully franked dividend of A$0.0394 per share for the six month period to 31 December 2025, with an ex date of 12 March, record date of 13 March, and payment on 31 March. At the same time, Viva Energy reported full year sales of A$28,528.7m and a net loss of...
XTRA:PUM
XTRA:PUMLuxury

Frasers Becomes Key Puma Shareholder And Raises Questions On Valuation And Debt

Frasers Group, controlled by Mike Ashley, has acquired a substantial stake in Puma, listed as XTRA:PUM. The purchase makes Frasers Group the second largest shareholder in the German sportswear company. This change in the shareholder base adds a new, high profile investor with a track record in retail and sports brands. Puma, traded as XTRA:PUM, is a global sportswear and footwear company that competes with major athletic brands for performance and lifestyle consumers. The sector continues...
NasdaqGS:CWST
NasdaqGS:CWSTCommercial Services

Is Casella Waste Systems (CWST) Fairly Priced After Recent Share Price Pullback?

If you are wondering whether Casella Waste Systems at around US$94.03 is a fair deal or a stretch, you are not alone. This article focuses squarely on what the current price might imply about value. The stock has moved 0.9% over the past week, while showing a 10.1% decline over 30 days, a 4.7% decline year to date, a 16.4% decline over 1 year, but gains of 24.7% over 3 years and 45.3% over 5 years. Recent price moves sit against a backdrop where investors are watching the waste and recycling...
NYSE:FSS
NYSE:FSSMachinery

Federal Signal’s Record Results, Dividend Hike And Board Moves Challenge Valuation

Federal Signal (NYSE:FSS) reported record quarterly and full year results, with net sales and adjusted EPS at the highest levels in the company’s history. The company announced a meaningful dividend increase alongside these results. Federal Signal also appointed two experienced executives to its board of directors. Federal Signal, listed on the NYSE under ticker FSS, focuses on safety and environmental solutions, including equipment and systems used by municipal, industrial, and commercial...
NasdaqGM:CRMD
NasdaqGM:CRMDPharmaceuticals

CorMedix (CRMD) Is Down 9.4% After Reaffirming 2026 Guidance and Reporting Profit Swing - What's Changed

CorMedix Inc. has reported past fourth-quarter 2025 revenue of US$128.62 million and net income of US$14.02 million, capping a year in which full-year revenue reached US$311.71 million and net income swung to US$163.06 million from a prior loss. The company’s reiteration of 2026 net revenue guidance of US$300 million to US$320 million, alongside advancing late-stage trials for REZZAYO and other pipeline assets, highlights management’s focus on consolidating recent product gains while...
OM:EKTA B
OM:EKTA BMedical Equipment

Assessing Elekta (OM:EKTA B) Valuation After Earnings Reset Expectations And China Growth Signals

Elekta (OM:EKTA B) drew fresh attention after its latest earnings update, where lower sales and net income figures sat alongside a strong book to bill ratio, solid China growth and ongoing cost saving efforts. See our latest analysis for Elekta. The latest earnings release appears to have reset expectations, with Elekta’s 1 day share price return of 9.64% lifting the share price to SEK62.0 and adding to a 30 day share price return of 11.91%. However, the 5 year total shareholder return of...
XTRA:AOF
XTRA:AOFSoftware

ATOSS’s Expanding Cloud Subscriptions Might Change The Case For Investing In ATOSS Software (XTRA:AOF)

In recent updates, ATOSS Software AG, a German workforce management specialist, reported continued strong performance underpinned by its recurring software fees and cloud subscription model, reinforcing its profile as a profitable, high-margin SaaS provider. An interesting angle for investors is ATOSS’s exposure to complex European labor markets, where stringent workforce regulations can underpin demand for its scheduling and compliance tools while offering diversification outside more...
NYSE:DFH
NYSE:DFHConsumer Durables

Assessing Dream Finders Homes (DFH) Valuation After Recent Share Price Weakness And Low P/E Ratio

Dream Finders Homes (DFH) has drawn investor attention after recent trading left the stock at US$16.40, with declines over the past week, month, and past 3 months raising questions about what is priced in. See our latest analysis for Dream Finders Homes. At US$16.40, the recent 1 day, 7 day and 30 day share price returns of 4.93%, 9.24% and 16.20% respectively point to fading near term momentum. The 1 year total shareholder return of 35.36% contrasts with a 3 year total shareholder return of...
NasdaqGM:PDYN
NasdaqGM:PDYNMachinery

A Look At Palladyne AI (PDYN) Valuation After 2026 Guidance And Backlog Expansion

Palladyne AI (PDYN) is back in focus after reporting Q4 and full year 2025 results, along with a fresh look at its 2026 outlook that combines earnings, guidance and backlog updates in one announcement. See our latest analysis for Palladyne AI. The latest earnings and guidance update landed after a sharp run in the shares, with a 7 day share price return of 21.34% and a 90 day share price return of 55.94% that point to building momentum despite a 14.36% pullback in the last session. The 3 year...
NYSE:RNST
NYSE:RNSTBanks

Earnings Beat, Dividend Hike and Insider Sale Could Be A Game Changer For Renasant (RNST)

In early March 2026, Renasant reported fourth-quarter 2025 results that beat analyst expectations, approved a US$0.23 per share quarterly dividend for payment on March 31, 2026, and disclosed an insider sale of 1,350 shares by EVP and Chief Accounting Officer Kelly Hutcheson. At the same time, investors grew more cautious about regional banks’ exposure to opaque private credit after a peer’s large loan write-off raised questions about hidden balance sheet risks across the sector. Against...
SGX:BSL
SGX:BSLHealthcare

Assessing Raffles Medical Group (SGX:BSL) Valuation After Strong 2025 Results And Proposed Final Dividend

Raffles Medical Group (SGX:BSL) is back in focus after reporting full year 2025 results and proposing a final ordinary dividend of 3.0 Singapore cents per share, subject to shareholder approval in April 2026. See our latest analysis for Raffles Medical Group. The earnings and dividend announcement comes after a mixed share price run, with a 1 month share price return of 3.5% and a 3 month share price return of 4.6%. However, the 3 year total shareholder return shows a 17.2% decline,...
NYSE:RLJ
NYSE:RLJHotel and Resort REITs

Did RLJ Lodging Trust’s (RLJ) 2025 EPS Collapse and Modest Buybacks Just Shift Its Investment Narrative?

In February 2026, RLJ Lodging Trust reported fourth quarter 2025 revenue of US$328.59 million and net income of US$0.43 million, alongside full-year 2025 revenue of US$1.35 billion and net income of US$28.51 million, both lower than the prior year. Despite completing a relatively small US$4.3 million share repurchase program covering 586,417 shares, the more striking development was the sharp fall in full-year earnings per share from continuing operations to US$0.01, highlighting pressure on...